Articular Manifestations in Inflammatory Bowel Disease: Prevalence and Clinical Insights
Articular manifestations are recognized as significant extraintestinal symptoms associated with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease (CD), ulcerative colitis (UC), and indeterminate colitis. These manifestations can appear before, during, or after intestinal symptoms, making their early detection crucial. Failing to recognize these symptoms can lead to substantial functional impairment and irreversible structural damage. A recent retrospective study conducted at the Department of Hepato-Gastroenterology at Mohammed VI University Hospital in Marrakech, Morocco, sheds light on this critical aspect of IBD.
In this study, researchers evaluated 150 patients diagnosed with IBD over a period from December 2023 to December 2024. Out of these, 60 patients demonstrated articular manifestations, yielding a prevalence rate of 40%. The findings revealed that CD affected 33 patients (55%), while UC was present in 24 (40%) and indeterminate colitis in three (5%). Interestingly, a notable female predominance was observed, with 68.3% of the affected individuals being women. The study also highlighted that joint symptoms often emerged after the diagnosis of IBD in 61.7% of the cases, while 28.3% experienced symptoms prior to their intestinal diagnosis, indicating a complex interplay between the gut and joint symptoms.
Clinical Patterns and Management of Articular Symptoms
The study categorized the clinical patterns of joint involvement, identifying mixed axial and peripheral manifestations as the most common, affecting 58.3% of patients. This was followed by isolated peripheral involvement in 26.7% and isolated axial involvement in 15%. Among the axial manifestations, inflammatory back pain was reported in 73.3% of patients, with buttock pain noted in 61.7%. These patterns underscore the importance of comprehensive evaluations of both axial and peripheral symptoms during routine follow-ups for IBD patients.
Biological assessments revealed systemic inflammation, with significant findings such as leukocytosis and elevated inflammatory markers in a substantial portion of patients. Moreover, radiographic evaluations identified sacroiliitis in 41.7% of the patients, indicating a need for vigilant screening during the management of IBD. The therapeutic approach was tailored to each patient, considering the type and severity of both IBD and the articular manifestations. A multidisciplinary strategy involving gastroenterologists and rheumatologists was deemed essential for optimal management and improved patient outcomes.
This study underscores the necessity for systematic screening of musculoskeletal symptoms in patients with IBD, promoting early diagnosis and intervention. As the interplay between gut health and joint symptoms becomes increasingly understood, it is imperative for healthcare professionals to remain vigilant in recognizing these manifestations to prevent long-term complications.
As reported by cureus.com.
